Your download link

October 13, 2026

Bonus Content: Five Big Banks Report Tuesday. The 5.24% Treasury Yield Changes Everything.


A note from our friends at Profits Run(ad)

If you haven’t downloaded my “Top 10 Stocks to Buy This Quarter” report yet, please do it right now.

It takes about five seconds.

And once we swap in next quarter’s list, this edition won’t be available anymore.

Download it here

Good Trading,

Bill Poulos

p.s. It’s the 10 stocks we like most right now, each one explained in plain English. Normally $29.97. Free here.

 
 
 
Bonus Article

Five Big Banks Report Tuesday. The 5.24% Treasury Yield Changes Everything.

Tuesday’s pre-market window is among the most data-dense sessions of the quarter. JPMorgan Chase, Goldman Sachs, Wells Fargo, Citigroup, UnitedHealth Group, and Johnson & Johnson all report before the opening bell, and the macro backdrop makes each result materially harder to read than it was 90 days ago.

Market Context

The 10-year Treasury yield held at 5.24% into Monday’s Columbus Day session, with cash bond markets closed and equity markets left without their primary rate reference. Oil climbed above $94 a barrel following weekend Houthi strikes on targets in and around Riyadh’s airport complex, and U.S. equities were mixed with the Nasdaq underperforming. University of Michigan consumer sentiment came in at 46.3 against a 47.6 estimate, the second-lowest reading on record. The VIX edged up to 15.21. Bonds reopen Tuesday, meaning yields will move again just as executives take the earnings call microphone.

The broader earnings season sets a high bar. FactSet projects S&P 500 Q3 EPS growth of 29.5% year-over-year, which would be the third consecutive quarter above 25%. A record 72 companies issued positive Q3 EPS guidance ahead of the season, well above the five-year average of 42.

Sector Breakdown: Financials Under the Yield Curve

Banks entered Q3 earnings season with bank stock prices under pressure from rising yields, even as fundamentals improved. Five major investment banks are expected to generate roughly $38 billion in combined trading revenue for the quarter, a meaningful step down from the record $47 billion in Q2, though still approximately 13% ahead year-over-year. The directional question Tuesday is whether equities desk strength at Goldman and JPMorgan can offset softer fixed-income trading, and whether investment-banking fee pipelines are converting into recognized revenue.

Consumer staples, utilities, and energy led sector performance in the prior week, each gaining roughly 3.5% to 3.9%. Technology and high-beta names failed to hold relative breakout levels, a pattern that makes Tuesday’s bank results a potential rotation catalyst if they beat cleanly.

Stock-Specific Breakdown

JPMorgan Chase (JPM): Consensus sits at $5.90–$5.93 EPS on revenue of approximately $51.2 billion, up roughly 9% from $47.1 billion a year ago. Net interest income is forecast to rise 12% to $26.84 billion, the cleanest signal for core loan-and-deposit momentum. After Q2, JPMorgan raised its full-year NII guidance to $105.5 billion from $103 billion. The bar is high: Q2 ROTCE was 29% including a $4.6 billion Visa-related gain, or 23% excluding significant items. Options markets are pricing a move of roughly ±4% around earnings day, above JPM’s typical realized move.

Goldman Sachs (GS): Estimates for Q3 EPS range from $12.86 to $15.18, an unusually wide spread that reflects genuine model uncertainty. Revenue consensus is near $16.83 billion, up about 11% from $15.18 billion a year ago but down roughly 17% sequentially from Q2’s record $20.34 billion. Goldman’s stock closed Friday at $895.32. The key pivot is whether equities desk strength offsets softer FICC revenue and whether expense discipline holds as compensation and non-compensation costs reset off a record quarter.

UnitedHealth Group (UNH): Consensus EPS of $4.12 on $111.3–$111.4 billion in revenue implies a 41% jump from the $2.92 reported a year ago. The medical care ratio is the decisive variable. It improved from 89.4% in Q2 2025 to 86.7% in Q2 2026, a significant recovery tied to pricing and mix. UNH shares recently traded near $378. Full-year Medicare Advantage enrollment is expected to decline by approximately 1.1 million members in 2026 as the company deliberately sheds unprofitable plans. Average analyst price targets stand at $487.22, implying approximately 29% upside from the recent reference price if the MCR trajectory holds.

Wells Fargo (WFC): Consensus at $1.85 EPS on $22.4 billion in revenue (+4.7% year-over-year), with NII growth of 5.5% expected despite margin pressure. Wells Fargo carries more rate sensitivity than peers, making Tuesday’s guidance commentary on deposit costs as important as the Q3 headline.

Technical Framework

JPM pulled back roughly 11% from its August 13 all-time high of $366.50 to an October 1 low near $325.87, a decline that stalled near its 200-day moving average and a 61.8% Fibonacci retracement of the prior medium-term leg. That confluence makes $325–$330 the structural floor heading into Tuesday’s report. A clean beat that holds $340 intraday would shift the technical posture; a miss or weak guidance that breaks the 200-day could accelerate selling into the broader bank group. GS at $895 sits near multi-month support; a miss risks re-testing $850.

The SOX (Philadelphia Semiconductor Index) fell 2.7% Monday. Nasdaq breadth has deteriorated: only about 35% of S&P 500 stocks traded above their 50-day moving average, up from near 20% but still historically depressed. A strong bank open could improve breadth without necessarily lifting tech.

Scenario Modeling

Bull Case: JPMorgan beats on EPS and raises its full-year NII guidance above $106 billion. Goldman’s equities revenue offsets FICC softness and hits the high end of the $12.86–$15.18 range. UNH posts an MCR below 86% for Q3, confirming the pricing cycle. The 10-year yield retreats toward 5.10% on Wednesday’s CPI data reading at or below the 3.6% consensus, and the KBW Bank Index recovers 3%–4% by week-end.

Base Case: Banks report inline-to-modest beats. JPM EPS comes in near $5.90–$6.00. Goldman lands near the midpoint of estimate ranges. UNH MCR prints in the 86%–87% range, consistent with Q2, and shares stabilize near $380–$395. The 10-year yield stays above 5.10%, capping multiple expansion for financials. Bank stocks gain 1%–2% on the day before fading into CPI week.

Bear Case: Goldman’s FICC weakness is deeper than expected and expenses compress ROE materially below 20%. UNH’s MCR deteriorates back toward 88%, raising questions about the sustainability of the recovery. JPMorgan issues cautious language on 2027 NII as deposit costs accelerate. The 10-year yield spikes above 5.35% on hot CPI Wednesday, and the KBW Bank Index extends its October decline.

Active Trader Strategy Framework

Position sizing matters more than direction Tuesday. The roughly ±4% options-implied move on JPM alone is above its typical realized move, that is the market’s honest assessment of uncertainty, not a directional signal. Traders watching the UNH setup should treat the medical care ratio as the primary read, not the headline EPS number, which reflects one-time items and membership mix shifts. For Goldman, the spread between the low ($12.86) and high ($15.18) estimate reflects genuine model divergence, focus on management commentary around FICC client activity and expense trajectory on the call. The NFIB Small Business Optimism release at 6 a.m. ET and existing home sales at 2 p.m. ET provide bookends to a session that will be dominated by earnings in the morning hours. Wednesday’s CPI is the next macro lever.

Conclusion

Tuesday is a stress test for the earnings-optimism trade. Five major financials reporting simultaneously against a 5.24% 10-year yield, a weakened consumer sentiment backdrop, and a chip sector already under pressure creates cross-currents that reward preparation over conviction. Know your levels, know the specific metrics that matter for each name, and let the reports define the range before adding exposure.

More From Author

$300B in Stablecoins Has Never Faced a Real Crisis

5 Urgent Steps to Take Now

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Categories